Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Clinical trial NCT04981509 · RECRUITING

Trial details

NCT number: NCT04981509
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hereditary Leiomyomatosis and Renal Cell Carcinoma Papillary Renal Cell Carcinoma Renal Cell Carcinoma Sporadic Papillary Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8

Start date: 2022-06-10
Primary completion: 2027-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.